Evaluation of tumor mutation burden (TMB) in tumor (tDNA) and plasma cell free DNA (cfDNA) in patients (pts) with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with a combination of cetuximab and nivolumab (C+N)
Chung, Christine H., Moorhead, Graydon, Haradhvala, Nicholas, Parida, Laxmi, Li, Jiannong, Slebos, Robbert, Song, Xiaofei, Chaudhary, Ritu, Poole, Maria, Park, Robin, Kirtane, Kedar, Steuer, Conor Ernst, Saba, Nabil F., Bhateja, Priyanka, Rocco, James William, Bonomi, Marcelo Raul, Danysh, Brian, Getz, Gad, Tan, Aik-choon
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Association of neutrophil-lymphocyte ratio (NLR) with clinical outcomes in patients (pts) with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with combination of cetuximab and nivolumab (C+N)
Park, Robin, Rind, Fahad, Kristoff, Tyler, Li, Jiannong, Slebos, Robbert, Thatikonda, Sowjanya, Chaudhary, Ritu, Poole, Maria, Kaldas, David, Farinhas, Joaquim, Hernandez-Prera, Juan C., Kirtane, Kedar, Rocco, James William, Bhateja, Priyanka, Steuer, Conor Ernst, Saba, Nabil F., Bonomi, Marcelo Raul, Chung, Christine H.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Concurrent cetuximab (CTX) and nivolumab (NIVO) in patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Results of phase II study
Chung, Christine H., Bonomi, Marcelo Raul, Steuer, Conor Ernst, Schell, Michael J., Li, Jiannong, Johnson, Matthew, Masannat, Jude, Hernandez-Prera, Juan C., McMullen, Caitlin, Wadsworth, J, Patel, Krupal, Kish, Julie Ann, Muzaffar, Jameel, Kirtane, Kedar, Rocco, James William, Saba, Nabil F.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Efficacy of concurrent cetuximab (CTX) and nivolumab (NIVO) in previously untreated recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
Chung, Christine H., Saba, Nabil F., Steuer, Conor Ernst, Li, Jiannong, Bhateja, Priyanka, Johnson, Matthew, Masannat, Jude, Poole, Maria, Hoening, Dirk, Song, Feifei, Hernandez-Prera, Juan C., Molina, Helen, Wenig, Bruce, Farinhas, Joaquim, Kish, Julie Ann, Muzaffar, Jameel, Kirtane, Kedar, Rocco, James William, Schell, Michael J., Bonomi, Marcelo Raul
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Expansion cohort validation of a clinical predictive model for head and neck cancer survival in patients treated with immune checkpoint inhibitors
Laliotis, Georgios I., Issa, Majd, Klamer, Brett, Karivedu, Vidhya, Bhateja, Priyanka, Dibs, Khaled, Mladkova, Nikol, Pan, Xueliang Jeff, Old, Matthew O., Gamez, Mauricio, Grecula, John C., Jhawar, Sachin R, Mitchell, Darrion L, Baliga, Sujith, Carrau, Ricardo, Rocco, James William, Blakaj, Dukagjin, Bonomi, Marcelo Raul
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Use of cetuximab added to weekly chemotherapy to improve progression-free survival in patients with recurrent metastatic head and neck squamous cell carcinoma after progression on immune checkpoint inhibitors
Issa, Majd, Klamer, Brett, Karivedu, Vidhya, Bhateja, Priyanka, Laliotis, Georgios I., Dibs, Khaled, Mladkova, Nikol, Pan, Xueliang Jeff, Old, Matthew O., Gamez, Mauricio, Grecula, John C., Jhawar, Sachin R, Mitchell, Darrion L, Baliga, Sujith, Carrau, Ricardo, Rocco, James William, Blakaj, Dukagjin, Bonomi, Marcelo Raul
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article